Jian-Yi Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian-Yi Zheng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ren-Dan Zhang
Department of Geriatrics, Shenzhen Longhua District Central Hospital, Shenzhen, Guang Dong, P.R. China
1 shared publication Rong Chen
Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China
1 shared publication- Tu-Di Li
Cardiovascular Department of First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China
1 shared publication Tudi Li
Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China
1 shared publicationXing Yu
Vasculocardiology Department, The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510080, P. R. China
1 shared publication- Yan-Qun Zhao
Cardiovascular Department of First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 30 March 2020
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 21 (1) , 147-153
Impact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol
The purpose of this study is to investigate the effect of lipoprotein(a) level on long-range prognosis after Percutaneous Coronary Intervention (PCI) in patients with low-density lipoprotein cholesterol (LDL-C) goal attainment. In this retrospective study, 350 patients in Coronary artery disease (CAD) with LDL-C less than 1.8 mmol/L were enrolled in the Guangdong Institute of Cardiovascular Diseases from January 2011 to December 2013. Follow-up was 1 year after PCI. According to the median value of the study population based on Lp(a), the patients were assigned to the high-level group and low-level group. The clinical data of the 2 groups were collected. We compared the baseline data between the 2 groups and the incidence rate of major cardiovascular events. After statistical analysis, the gender composition, hypertension, diabetes, and age of the patients between the 2 groups were similar, and the distinction was not significant. There was no significant distinction in cardio-vascular death, ischemic stroke, and recurrent myocardial infarction between the 2 groups, but the incidence of revascularization was higher in the high-level group (P < 0.05). High Lp(a) level predicts an increased incidence of revascularization of patients in CAD with LDL-C less than 1.8 mmol/L after PCI.
- 30 March 2020
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 21 (1) , 147-153
Open AccessImpact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol
The purpose of this study is to investigate the effect of lipoprotein(a) level on long-range prognosis after Percutaneous Coronary Intervention (PCI) in patients with low-density lipoprotein cholesterol (LDL-C) goal attainment. In this retrospective study, 350 patients in Coronary artery disease (CAD) with LDL-C less than 1.8 mmol/L were enrolled in the Guangdong Institute of Cardiovascular Diseases from January 2011 to December 2013. Follow-up was 1 year after PCI. According to the median value of the study population based on Lp(a), the patients were assigned to the high-level group and low-level group. The clinical data of the 2 groups were collected. We compared the baseline data between the 2 groups and the incidence rate of major cardiovascular events. After statistical analysis, the gender composition, hypertension, diabetes, and age of the patients between the 2 groups were similar, and the distinction was not significant. There was no significant distinction in cardio-vascular death, ischemic stroke, and recurrent myocardial infarction between the 2 groups, but the incidence of revascularization was higher in the high-level group (P < 0.05). High Lp(a) level predicts an increased incidence of revascularization of patients in CAD with LDL-C less than 1.8 mmol/L after PCI.
- Open Access
- 5 September 2017
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 12 (1) , 1-5
Left atrial myxoma complicated with multi-system embolization
Atrial myxoma accounts for approximately 50% of all cardiac tumors. The majority of myxomas are located in the left atrium and present variable clinical manifestation. A young man was transferred to our hospital with sudden onset of resting pain, pallor and numb in right leg. An atrial mobile mass was detected by transthoracic echocardiography. Anticoagulant and antithrombotic therapy were administered, a timely surgery was performed and the mass was confirmed as a myxoma. The patient did not discharge any discomfort post-operation. For patients with atrial myxoma, early diagnosis is essential, anticoagulant or antithrombotic therapy and surgery have a great importance to prevent further embolism.
- 5 September 2017
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 12 (1) , 1-5
Open AccessLeft atrial myxoma complicated with multi-system embolization
Atrial myxoma accounts for approximately 50% of all cardiac tumors. The majority of myxomas are located in the left atrium and present variable clinical manifestation. A young man was transferred to our hospital with sudden onset of resting pain, pallor and numb in right leg. An atrial mobile mass was detected by transthoracic echocardiography. Anticoagulant and antithrombotic therapy were administered, a timely surgery was performed and the mass was confirmed as a myxoma. The patient did not discharge any discomfort post-operation. For patients with atrial myxoma, early diagnosis is essential, anticoagulant or antithrombotic therapy and surgery have a great importance to prevent further embolism.